Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000950170-25-021481·ARROWHEAD PHARMACEUTICALS, INC.
Schedule 13D ownership disclosure
ARROWHEAD PHARMACEUTICALS INC COM
Common stock, par value $0.001 per share (the "Common Stock") · CUSIP: 04280A100
Event date: 2025-02-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sarepta Therapeutics, Inc.Reported CIK 0000873303
Shares: 11,926,301 · Class: 9.5%
- Sarepta Therapeutics Investments, Inc.
Shares: 11,926,301 · Class: 9.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021481
- Form type
- SCHEDULE 13D
- Filer
- ARROWHEAD PHARMACEUTICALS, INC.
- CIK
- CIK 879407
- Filed
- Feb 14, 2025
- Reporting period
- Feb 07, 2025
- Description
- Schedule 13D beneficial ownership